Align Technology Stock Analysis
ALGN is currently below model estimate with Market Value of 0.0 and Intrinsic Value of 0.0. ALGN valuation begins with estimating what the business generates versus what the market charges for it. Fundamental metrics and price behavior for ALGN are examined below to identify alignment or divergence between the two signals.
ALGN holds a debt-to-equity ratio of 0.03 relative to health care peers. Rising leverage combined with declining revenue creates a compounding risk dynamic for Align Technology. Dividend capacity can be constrained when debt covenants prioritize creditor claims over shareholder distributions. Asset vs Debt
Equity vs Debt
Align Technology |
Investor Insights and Alerts
| Align Technology is not yet fully synchronised with the market data | |
| Align Technology has some characteristics of a very speculative penny stock |
Thematic Classifications
A thematic view of Align Technology is valuable because it lets investors test the idea inside a broader opportunity set instead of judging the security in isolation. Used well, thematic analysis can turn a discretionary idea into a more systematic portfolio-building process with clearer risk boundaries.
 | CannabisCompanies involved in production or distribution of medical cannabis | |
 | Obamacare RepealLarge healthcare related equities associated with Obamacare | |
 | Trump EquitiesCompanies that have responded positively to Trump presidency |
Market Capitalization
At roughly $12.31 billion, Align Technology belongs to the large-cap segment of health care companies. Related valuation data points include a workforce of about 20,290 people, operating in the Health Care industry, and enterprise value near $11.84 billion.Profitability
Profitability analysis for Align Technology focuses on how well revenue converts into operating income, net income, and free cash flow. The best read combines margin history with balance-sheet strength and pricing power under softer demand. ALGN has Profit Margin (PM) of 11.0%. Similarly, it shows Operating Margin (OM) of 18.0%.Insider Trading Activities
Insider disclosures for Align Technology show how people closest to the business are behaving as market expectations change. U.S. insider activity is disclosed through Form 4 filings, enabling analysis of transaction timing, clustering, and scale.
Outstanding Bonds
Corporate bonds issued by Align Technology matter because they shape interest expense, maturity risk, and the flexibility management has during tighter credit conditions. Maturity profile, refinancing windows, and coupon burden can all affect how resilient the capital structure looks in a weaker market.
| ATDBCN 355 26 JUL 27 Corp BondUS01626PAH91 | View | |
| ATDBCN 295 25 JAN 30 Corp BondUS01626PAM86 | View | |
| ATDBCN 38 25 JAN 50 Corp BondUS01626PAN69 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Debt to Cash Allocation
The debt-to-cash mix for Align Technology helps explain how management balances flexibility and funding cost through a business cycle.
Total debt stands at approximately $114.45 million with Debt to Equity (D/E) ratio of 0.03. Align Technology has a current ratio of 1.35, which is within standard range for the sector. Align Technology's use of debt should be considered alongside its cash position and equity base.Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Align Technology's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Align Technology, which in turn will lower the firm's financial flexibility.Corporate Bonds Issued
Stock Analysis Methodology
As a large-cap equity, Align Technology is scored on valuation, solvency, and operating efficiency. Align Technology operates in NASDAQ Composite Total within Cannabis in Obamacare Repeal. Financial distress probability is estimated at 9%, indicating low near-term solvency risk. Align Technology trades at P/E of 29.97, P/B of 3.09.
Align Technology figures are aggregated from periodic company reporting and market reference feeds and normalized across reporting formats.
Editorial review and methodology oversight provided by: Rifka Kats, Member of Macroaxis Editorial Board
Be Your Own Money Manager
A sound portfolio process for Align Technology should connect conviction, risk tolerance, and expected return before the position is added or expanded. The practical goal is to improve diversification, remove redundancy, and keep return expectations realistic.
Did You Try This?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
| All Next | Launch Module |
Align Technology has a market cap of 12.31 billion, an operating margin of 18.18% (TTM), current ratio of 1.38. Quarter-over-quarter changes in these metrics are often more informative than the current snapshot. Broader economic conditions can influence Align Technology's company valuation - related indicators include signals in price.Align Technology at P/E 29.97 and ROE 10.82% (USD 12.31 billion market cap) - this analysis works best as a complementary layer in the context of analysis of how the position fits in a broader portfolio. Additional scrutiny through the profitability and balance-sheet tools is warranted. You can also try the Competition Analyzer module to compare fundamental indicators side by side for a group of related or unrelated entities.
Related Tools for Align Technology Stock
Price behavior of Align Technology is best reviewed alongside fundamentals and sector positioning.
Stocks DirectoryFind actively traded stocks across global marketsPortfolio CenterAll portfolio management and optimization tools to improve performance of your portfoliosFundamental AnalysisView fundamental data based on most recent published financial statementsPortfolio HoldingsCheck your current holdings and cash position to determine if your portfolio needs rebalancingBond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios.Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments